MEET BEZZY, HEALTHLINE MEDIA’S NEW SUITE OF COMMUNITIES FOR PEOPLE LIVING WITH CHRONIC HEALTH CONDITIONS

3 years ago

SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ -- Today, Healthline Media is launching a suite of seven health condition communities through its new…

Phonak Becomes a Patron Partner of the American Tinnitus Association

3 years ago

Phonak Lyric™, the 100% Invisible Hearing Aid, is Clinically Proven to Provide Relief of TinnitusSTÄFA, SWITZERLAND / ACCESSWIRE / January…

Neuropathix, Inc. Receives Patent Grant from India for Its Novel Anti-Inflammatory Compounds

3 years ago

DOYLESTOWN, PA / ACCESSWIRE / January 18, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain…

Panacea Announces Launch of New Product COVID CBDA(TM)

3 years ago

"Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the…

Med-X Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

3 years ago

LOS ANGELES CA / ACCESSWIRE / January 18, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions…

9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer

3 years ago

Formerly served as VP of Finance and Commercial Operations at Biogen with 20+ years of business and strategic financial leadership…

MCOA Subsidiary cDistro Signs Distribution Agreement with Award Winning Realize Hemp Drinks

3 years ago

LOS ANGELES, CA / ACCESSWIRE / January 18, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), a…

Celcuity Receives FDA Fast Track Designation for Gedatolisib in HR+ / HER2- Metastatic Breast Cancer and Provides Corporate Update

3 years ago

FDA's Fast Track Designation for the pan-PI3K/mTOR inhibitor highlights potential to address the urgent need for new treatment options for…

Neutra’s VIVIS Excited to Release New Gummy!

3 years ago

KATY, TX / ACCESSWIRE / January 18, 2022 / Neutra Corp. (OTC PINK:NTRR) continues plans for Phase-1 clinical trials regarding…

Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology

3 years ago

ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its…